-
Je něco špatně v tomto záznamu ?
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks
V. Ďurmanová, I. Shawkatová, J. Javor, Z. Párnická, D. Čopíková-Cundráková, P. Turčáni, I. Lisá, B. Gajdošechová, M. Buc, M. Bucová,
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- alely MeSH
- dospělí MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci * MeSH
- HLA-DRB1 řetězec genetika MeSH
- integrin alfa4beta1 genetika MeSH
- jednonukleotidový polymorfismus genetika MeSH
- lidé MeSH
- roztroušená skleróza genetika MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Slovenská republika MeSH
Multiple sclerosis (MS) is an inflammatory autoimmune disease occurring in genetically sensitive individuals. As migration of immune cells into the CNS is facilitated by the Very Late Antigen 4 (VLA-4) integrin molecule, the VLA4 gene may be considered as a plausible candidate genetic risk factor for susceptibility to MS. Therefore, the objective of our study was to investigate the association between two genetic polymorphisms located in the VLA4 gene and the risk of multiple sclerosis. One hundred seventeen MS patients and 165 control subjects from Slovakia were genotyped for VLA4 gene SNP polymorphisms at positions 269 (C/A) and 3061 (A/G). The same study cohorts were also genotyped for the rs3135388 polymorphism tagging the HLA-DRB1*15:01 allele, which is a known genetic factor associated with susceptibility to develop MS in many populations. Our findings show for the first time that the rs3135388 polymorphism is a strong risk factor for MS in the Slovak population. Investigation of the VLA4 gene polymorphisms revealed a significantly higher frequency of the 3061AG genotype in MS patients compared to the controls (P ≤ 0.05). We suggest that the 3061AG polymorphic variant is an independent genetic risk factor for MS development in our population as it was significantly associated with this disease. The association was also confirmed after applying multivariate logistic-regression analysis adjusted for gender, age and HLA-DRB1*15:01 positivity as possible influencing factors.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16004159
- 003
- CZ-PrNML
- 005
- 20160215072146.0
- 007
- ta
- 008
- 160208s2015 xr f 000 0|eng
- 009
- AR
- 035 __
- $a (PubMed)25958306
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Ďurmanová, Vladimíra $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 xx0118475
- 245 10
- $a VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks / $c V. Ďurmanová, I. Shawkatová, J. Javor, Z. Párnická, D. Čopíková-Cundráková, P. Turčáni, I. Lisá, B. Gajdošechová, M. Buc, M. Bucová,
- 520 9_
- $a Multiple sclerosis (MS) is an inflammatory autoimmune disease occurring in genetically sensitive individuals. As migration of immune cells into the CNS is facilitated by the Very Late Antigen 4 (VLA-4) integrin molecule, the VLA4 gene may be considered as a plausible candidate genetic risk factor for susceptibility to MS. Therefore, the objective of our study was to investigate the association between two genetic polymorphisms located in the VLA4 gene and the risk of multiple sclerosis. One hundred seventeen MS patients and 165 control subjects from Slovakia were genotyped for VLA4 gene SNP polymorphisms at positions 269 (C/A) and 3061 (A/G). The same study cohorts were also genotyped for the rs3135388 polymorphism tagging the HLA-DRB1*15:01 allele, which is a known genetic factor associated with susceptibility to develop MS in many populations. Our findings show for the first time that the rs3135388 polymorphism is a strong risk factor for MS in the Slovak population. Investigation of the VLA4 gene polymorphisms revealed a significantly higher frequency of the 3061AG genotype in MS patients compared to the controls (P ≤ 0.05). We suggest that the 3061AG polymorphic variant is an independent genetic risk factor for MS development in our population as it was significantly associated with this disease. The association was also confirmed after applying multivariate logistic-regression analysis adjusted for gender, age and HLA-DRB1*15:01 positivity as possible influencing factors.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $7 D005787
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a HLA-DRB1 řetězec $x genetika $7 D059811
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a integrin alfa4beta1 $x genetika $7 D039041
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a roztroušená skleróza $x genetika $7 D009103
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 651 _2
- $a Slovenská republika $7 D018154
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Shawkatová, Ivana $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 xx0230777
- 700 1_
- $a Javor, Juraj $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 xx0073329
- 700 1_
- $a Párnická, Zuzana $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 xx0128170
- 700 1_
- $a Čopíková-Cudráková, Daniela $u 1st Department of Neurology, School of Medicine, Comenius University in Bratislava and University Hospital, Bratislava, Slovakia $7 xx0149295
- 700 1_
- $a Turčáni, Peter $u 1st Department of Neurology, School of Medicine, Comenius University in Bratislava and University Hospital, Bratislava, Slovakia $7 xx0121737
- 700 1_
- $a Lisá, Iveta $u 2nd Department of Neurology, School of Medicine, Comenius University in Bratislava and University Hospital, Bratislava, Slovakia $7 xx0256519
- 700 1_
- $a Gajdošechová, B. $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 _AN086000
- 700 1_
- $a Buc, Milan, $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $d 1944- $7 mzk2006353952
- 700 1_
- $a Bucová, Mária $u Institute of Immunology, School of Medicine, Comenius University in Bratislava, Slovakia $7 mzk2007390479
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 61, č. 1 (2015), s. 8-13
- 856 41
- $u https://fb.cuni.cz/file/5767/fb2015a0002.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20160208 $b ABA008
- 991 __
- $a 20160210143344 $b ABA008
- 999 __
- $a ok $b bmc $g 1107491 $s 928427
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 61 $c 1 $d 8-13 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20160208